Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

ConditionsStaphylococcus Aureus Bacteraemia Staphylococcal Bacteraemia Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)Staphylococcus (S.) Aureus Infection

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age18+

SponsorRegion Skane

About this trial

The goal of this study is to investigate if benzylpenicillin is a better treatment option than cloxacillin in patients with penicillin-susceptible Staphylococcus aureus bacteraemia.

Eligibility criteria

Qualifiers

None

Disqualifiers

allergy to penicillin,

inability to give informed consent,

concomitant growth of other clinically significant bacteria in blood cultures

neutropenia

Trial design

Treatments tested in this trial

Penicillin G_1200mg
cloxacillin

Treatment groups

420 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Region Skane

Lead sponsor

Source ClinicalTrials.gov